Cancer Family
Cutaneous Hematopoietic and Lymphoid Cell Neoplasm
CI-CAN-00000153Explore in graph →
HematologicNon-malignant69 active trials10 approved drugs
- NCIt
- C45240
Loading cancer entity…
Cancer Family
CI-CAN-00000153Explore in graph →
Clinical trials
371 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06470451 | Confirmatory Study of Topical HyBryte™ vs. Placebo for the Treatment of CTCL(FLASH2) | terminated | Phase 3 | 70 | SoligenixINDUSTRY | 1 | Jul 13, 2026 | clinicaltrials |
| NCT02811783 | Naloxone Hydrochloride Study for Relief of Pruritus in Patients With MF or SS Forms of CTCL | terminated | Phase 3 | 59 | Elorac, Inc.INDUSTRY | 1 | Oct 28, 2022 | clinicaltrials |
| NCT00127881 |
| Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome |
| terminated |
| Phase 3 |
| 76 |
| Emergent Product Development Seattle LLCINDUSTRY |
| 5 |
| Jul 26, 2012 |
| clinicaltrials |
Data updated 23 days agoSource updated Jul 13, 2026source: clinicaltrials